BIOMARIN PHARMACEUTICAL INC.

Lobbying client · California · filed 2025 to 2026

$2,190,000 Reported spend

6 Filings counted

1 Firms hired

9 Bills named

Spend is reported income plus in-house expenses across 6 filings. 2 further filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the client's LDA id (197314), not by name.

Firms hired 1

BIOMARIN PHARMACEUTICAL INC. $2,190,000 6 filings

Bills named in these filings 9

HR 1262
Mikaela Naylon Give Kids a Chance Act

4 filings
HR 1509
Accelerating Kids’ Access to Care Act of 2025

4 filings
S 1637
MVP Act

3 filings
S 752
Accelerating Kids’ Access to Care Act

3 filings
S 932
Give Kids a Chance Act of 2025

2 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

1 filing
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…

1 filing
HR 946
ORPHAN Cures Act

1 filing
S 1862
ORPHAN Cures Act

1 filing

Reported by year 2 years

2026 $870,000 2 filings
2025 $1,320,000 4 filings

Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 7

HOUSE OF REPRESENTATIVES 6
SENATE 6
Commerce, Dept of (DOC) 4
Health & Human Services, Dept of (HHS) 3
Food & Drug Administration (FDA) 2
Executive Office of the President (EOP) 1
Health Resources & Services Administration (HRSA) 1

Recent filings 8 total

2A

BIOMARIN PHARMACEUTICAL INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $340,000 expenses · posted Jul 20, 2026

View → 2A

BIOMARIN PHARMACEUTICAL INC. Amended

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $340,000 expenses · posted Jul 20, 2026

View → Q2

BIOMARIN PHARMACEUTICAL INC. Amended

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $340,000 expenses · posted Jul 20, 2026

View → Q1

BIOMARIN PHARMACEUTICAL INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $530,000 expenses · posted Apr 20, 2026

View → Q4

BIOMARIN PHARMACEUTICAL INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $390,000 expenses · posted Jan 20, 2026

View → Q3

BIOMARIN PHARMACEUTICAL INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $270,000 expenses · posted Oct 20, 2025

View → Q2

BIOMARIN PHARMACEUTICAL INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $270,000 expenses · posted Jul 21, 2025

View → Q1

BIOMARIN PHARMACEUTICAL INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $390,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.